Journal of Arrhythmia

Journal of Arrhythmia is the bimonthly open-access journal of the Japanese Heart Rhythm Society, issued by Wiley from Tokyo and given over to clinical cardiac electrophysiology, pacing and implanted device therapy.《心律失常杂志》（Journal of Arrhythmia）是日本不整脈心電学会的会刊，由 Wiley 在东京出版，双月一期，内容集中于临床心脏电生理、起搏与植入器械治疗。

Research papers, reviews and short signed commentaries fill its pages, and the 2025 Journal Impact Factor of 1.9 puts the title 151st among 237 journals in the cardiac and cardiovascular systems category.该刊刊发研究论文、综述与短篇署名评论，2025 年影响因子为 1.9，在心脏与心血管系统类目的 237 种期刊中列第 151 位。

Scope

• Atrial fibrillation takes the largest share of clinical content, spanning epidemiology, substrate characterisation, pulmonary vein isolation and the long-term rhythm outcomes of ablation.心房颤动占据临床稿件的主体，涵盖流行病学、基质标测、肺静脉隔离以及消融后的远期节律结局。
• Ventricular arrhythmias carry comparable weight, from scar-related ventricular tachycardia in structural heart disease to defibrillator programming and the management of electrical storm.室性心律失常的分量相当，从结构性心脏病中的瘢痕相关室性心动过速，到除颤器程控与电风暴处理。
• Ablation technique is a standing subject, with reports on mapping systems, cryoballoon and pulsed field energy, lesion formation and the avoidance of collateral injury.消融技术是常设主题，稿件涉及标测系统、冷冻球囊与脉冲电场能量、损伤形成以及邻近结构损伤的规避。
• Implanted devices are examined through implantation technique, lead performance, device infection and transvenous lead extraction, often in multicentre case series.植入器械方向考察植入技术、导线性能、器械感染与经静脉导线拔除，多为多中心病例系列。
• Conduction system pacing, covering His bundle and left bundle branch area pacing, has become a regular topic beside conventional biventricular resynchronisation.传导系统起搏涵盖希氏束与左束支区域起搏，已与常规双心室再同步治疗并列成为常规选题。
• Remote monitoring and device-derived data appear in studies of atrial high-rate episodes, in work on alert burden, and in accounts of what continuous rhythm surveillance does to clinic workflow.远程监测与器械生成的数据见于心房高频事件研究，也见于报警负担的讨论，以及持续节律监测对门诊流程影响的记录。
• Inherited arrhythmia syndromes receive steady attention, among them Brugada syndrome, the long and short QT syndromes and catecholaminergic polymorphic ventricular tachycardia.遗传性心律失常综合征受到持续关注，其中包括 Brugada 综合征、长与短 QT 综合征以及儿茶酚胺敏感性多形性室性心动过速。
• Genetic testing and family screening of affected kin are handled as part of that work, with reports on yield, counselling and the follow-up of carriers.基因检测与家系筛查属于同一方向的组成部分，稿件报告检出率、遗传咨询以及携带者的随访。
• Stroke prevention is treated as an element of rhythm care, covering direct oral anticoagulants, left atrial appendage occlusion and bleeding risk around ablation and cardioversion.卒中预防被视为节律管理的一环，讨论直接口服抗凝药、左心耳封堵，以及消融与复律前后的出血风险。
• Electrocardiography and monitoring technology run from twelve-lead interpretation and Holter analysis to smartwatch recordings and machine learning models for arrhythmia detection.心电图与监测技术从十二导联判读、动态心电图分析，一路延伸到智能手表记录与心律失常检测的机器学习模型。
• Syncope, risk stratification and sudden cardiac death form a heading of their own, with tilt-table work, autonomic testing and outcome data from Japanese registries.晕厥、危险分层与心源性猝死自成一类，包含倾斜台试验、自主神经评估以及日本注册研究中的结局数据。
• Paediatric and congenital heart disease electrophysiology is covered through catheter ablation in small hearts, device implantation in congenital lesions and the transition to adult care.儿童与先天性心脏病电生理覆盖小体重心脏的导管消融、先天畸形中的器械植入，以及向成年期照护的过渡。
• Arrhythmia in heart failure is studied as a joint problem, asking when ablation restores ventricular function and which patients gain from resynchronisation.心力衰竭合并心律失常被当作联合问题处理，追问消融何时改善心室功能，以及哪些患者能从再同步治疗中获益。
• Epidemiology from Japan and the wider Asia-Pacific region supplies much of the journal's raw material, including registry reports and comparisons of practice between countries.日本与更广的亚太地区流行病学构成该刊多数素材，包括注册研究报告与跨国实践比较。
• Basic and translational work appears in smaller volume, on ion channel function, autonomic modulation and the tissue response to ablative energy.基础与转化研究数量较少，涉及离子通道功能、自主神经调控以及组织对消融能量的反应。

History

• The journal opened in August 2005 at volume 21, number 3, under the Japanese Society of Cardiac Pacing and Electrophysiology, which the National Library of Medicine still records as the original Tokyo imprint behind the title.该刊 2005 年 8 月以第 21 卷第 3 期开局，创办方是日本心脏起搏与电生理学会，美国国家医学图书馆的著录仍把这家东京学会列为最初的出版方。
• Volume numbers run one per calendar year, from a count that starts in 1985 and reached 31 in 2015 and 42 in 2026, which is why the 2005 opening came at volume 21 rather than volume 1, and the library carries the earlier Japanese-language series under the title Fuseimyaku.卷号一年一卷，计数自 1985 年起算，2015 年为第 31 卷，2026 年为第 42 卷，2005 年开局时因此已是第 21 卷，美国国家医学图书馆把这批早年的日文卷册记在（Fuseimyaku）这一题名之下。
• Wiley took over publication in 2018, after which the library records Tokyo and Wiley from that year onward, with the society remaining the owning body.2018 年起出版事务转由 Wiley 承担，美国国家医学图书馆自此把出版项记为东京与 Wiley，学会仍是刊物的所有者。
• From October 2011 the Asia Pacific Heart Rhythm Society has stood beside the Japanese body as a second owning society, a pairing the library record names explicitly.2011 年 10 月起，亚洲太平洋心律学会与日本学会并列，成为刊物的第二家主办学会，美国国家医学图书馆的著录对此写得很明确。
• Issues have been bimonthly since 2012 on the NLM record, Crossref deposits for 2024 through 2026 confirm six numbered issues inside each volume, and the print edition stopped with volume 27 in 2011.依美国国家医学图书馆著录，2012 年起为双月刊，2024 至 2026 年的 Crossref 登记同样显示每卷编到第 6 期，印刷版则在 2011 年第 27 卷之后停出。
• Volume 39 in 2023 carried two supplements alongside its six regular issues, an arrangement the volumes before and after did not repeat.2023 年第 39 卷在 6 期正刊之外另出两期附刊，前后各卷未再出现同样安排。
• PubMed coverage begins with volume 31, number 1 of February 2015, and the full text of published articles is deposited in PubMed Central.PubMed 收录起自 2015 年 2 月第 31 卷第 1 期，已刊论文的全文同步存入 PubMed Central。
• Open access has been the rule from the first volume, DOAJ dating it to 2005, and gold open access now accounts for 99.75 per cent of published output.自首卷起即实行开放获取，DOAJ 记录的起始年为 2005 年，金色开放获取目前占发文量的 99.75%。
• Authors meet an article processing charge of 1540 US dollars, with equivalents of 1190 pounds and 1410 euros quoted by DOAJ for the same licence terms.作者需支付 1540 美元的版面费，DOAJ 就同一授权条款另列 1190 英镑与 1410 欧元的等值金额。
• Clarivate indexes the title in the Emerging Sources Citation Index rather than the Science Citation Index Expanded, and the 2025 file places it in the third quartile.Clarivate 将该刊收入 Emerging Sources Citation Index 而非 Science Citation Index Expanded，2025 年榜单列第三四分位。
• The impact factor moved from 2.2 in 2023 to 1.7 in 2024 and back to 1.9 in 2025, against a five-year value of 1.8 and a Journal Citation Indicator of 0.42.影响因子 2023 年为 2.2，2024 年降至 1.7，2025 年回到 1.9，五年值为 1.8，期刊引文指标为 0.42。
• About 156 articles are counted each year, and roughly 1800 citations were credited to the title in the 2025 report over a cited half-life of 4.6 years.每年计入约 156 篇论文，2025 年报告计得被引约 1800 次，被引半衰期为 4.6 年。
• Crossref records for the journal have grown from about 191 items in 2023 to 227 in 2024 and 287 in 2025, and volume 42 already held some 250 items during 2026.Crossref 的登记量从 2023 年的约 191 条增至 2024 年的 227 条与 2025 年的 287 条，2026 年第 42 卷已录得约 250 条。
• The founding society appears in early imprints under its pacing and electrophysiology name, while the copyright line on current tables of contents credits the Japanese Heart Rhythm Society.早期著录中的创办机构用的是起搏与电生理学会之名，现行目次的版权行则署 Japanese Heart Rhythm Society。
• Print and electronic editions carry separate identifiers, ISSN 1880-4276 and eISSN 1883-2148, the electronic one being what Wiley uses on its platform.印刷版与电子版各有标识，分别为 ISSN 1880-4276 与 eISSN 1883-2148，Wiley 平台上的论文使用后者。
• Early View publication is standard, so accepted papers are listed under that heading until an issue is assembled and numbered.录用稿先在 Early View 下列出，待期次编排完成并取得卷期号后再移入正式目录。

Editors

• Between 2011 and 2015 the journal carried comments from the editor-in-chief signed by Kazutaka Aonuma, several of them setting out the title's aims for readers.2011 至 2015 年间，该刊多次刊出由 Kazutaka Aonuma 署名的总编辑致辞，其中数篇向读者说明办刊方向。
• Most original papers are paired with a short invited editorial headed "Editorial to" and signed by a commentator who places the findings in context.多数原创论文配有短篇邀约评论，题名以 Editorial to 起头，由评论人署名并把研究结果放回学科脉络。
• Those commentaries come mostly from Japanese university hospitals, with recurring contributions from groups based in Singapore and Taiwan.这些评论多出自日本各大学医院，新加坡与台湾的研究组亦有持续供稿。
• Review is single anonymous, meaning referees know who wrote the paper while authors are not told who assessed it, as the DOAJ record of the process states.评审采用单盲制，审稿人知晓作者身份，作者不知评审人是谁，DOAJ 对该刊流程的著录即如此。
• Manuscripts are screened for plagiarism before assessment, and submissions travel through Wiley's online system with the author guidelines as the operative rulebook.稿件在进入评估前须通过抄袭检测，投稿经 Wiley 在线系统提交，作者指南是实际执行的规则文本。
• Letters to the editor are indexed in their own right, and authors of the original paper are given room to answer the points raised against their work.读者来信单独被索引，原文作者可获篇幅回应针对其论文提出的质疑。
• Short formats hold a place of their own, and the December 2026 issue carries an In Memoriam piece on David S. Cannom written by Itsuro Morishima.短篇形制自有一席之地，2026 年 12 月号载有 Itsuro Morishima 撰写的 David S. Cannom 纪念文。
• Reviews form a minority of output, 23 of the 764 records indexed for 2023 through 2026 carrying the review tag in PubMed.综述在发文中所占比例有限，2023 至 2026 年 PubMed 收录的 764 条记录中有 23 条带综述标记。
• Randomised trials and meta-analyses are rare in that same window, and most clinical reports are observational, drawn from registries and single-centre cohorts.同一时段内随机试验与荟萃分析少见，临床报告以观察性研究为主，多取自注册登记与单中心队列。
• Copyright rests with the society rather than the publisher, as the line carried by the journal's table of contents service still states.版权归学会而非出版方所有，该刊目次服务的版权行仍作此标注。